MedTrace Logo

A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients

NCT04139252 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2023-04-26

No results posted yet for this study

Summary

Observational prospective study. Patients with DLBCL and HGBCL will be enrolled in the study to collect samples for developing a blood based assay allowing biomarker driven treatment in the future.

Conditions

  • NHL

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Stichting Hemato-Oncologie voor Volwassenen Nederland

    lead OTHER

Principal Investigators

  • M.E.D. Chamuleau, MD, PhD · VUmc

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-17
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04139252 on ClinicalTrials.gov